Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study

Background Parkinson’s disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging populations, longer disease duration and potentially as a COVID-19 sequela. Photobiomodulation (PBM) has been successfully used in animal mo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC neurology Jg. 21; H. 1; S. 1 - 15
Hauptverfasser:	Liebert, Ann, Bicknell, Brian, Laakso, E-Liisa, Heller, Gillian, Jalilitabaei, Parastoo, Tilley, Sharon, Mitrofanis, John, Kiat, Hosen
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 02.07.2021 BioMed Central Ltd Springer Nature B.V BMC
Schlagworte:	Aging Alzheimer's disease Animal models Brain research Care and treatment Clinical trials Cognition COVID-19 Dopamine receptors Ethics Laser therapy Lasers Light therapy Medicine Medicine & Public Health Mobility Motor skill Motor symptoms Movement disorders Neurochemistry Neurodegenerative diseases Neurology Neurosurgery Parkinson's disease Photobiomodulation Phototherapy Placebos Testing Therapy Australia Mobility Cognition Parkinson’s disease Photobiomodulation Motor symptoms
ISSN:	1471-2377, 1471-2377
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!